EGFR and neoplasm: Using strain as the random effect, we confirm previous reports [8]–[10] that pharmacologic inhibition of EGFR decreases small intestinal tumor number and size in the ApcMin/+ mice (Figure 2A, p = 0.003 and Figure 3A, p<0.001, respectively).